Apogee Therapeutics CMO Carl Dambkowski sells 5,500 common shares for $432,905

• Apogee Therapeutics Chief Medical Officer Carl Dambkowski sold 5,500 common shares on June 3 at USD 78.71.
• The filing also shows exercise of stock options for 4,125 shares at USD 22.86 on the same day.
• Dambkowski ended with 205,648 common shares beneficially owned.
• He also reported 118,915 stock options outstanding following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-071076), on June 05, 2026, and is solely responsible for the information contained therein.